endoscopic instruments have accentuated the effect of the surgeon's tremor, making completion of an anastomosis both difficult and time consuming. 7 Recent technological developments have addressed the difficulties associated with endoscopic CABG. 8, 9 To overcome the limitations of traditional endoscopic instruments, robotic systems have been developed to enhance surgical dexterity. We have used one of these systems to perform a prospective clinical trial of endoscopic CABG.
assisted endoscopic CABG. All patients underwent robotically assisted anastomosis of the left internal thoracic artery (LITA) to the left anterior descending coronary artery (LAD). Primary outcome measurements were device-related complications and graft patency at 6 to 8 weeks.
Methods
Patient selection. The Food and Drug Administration approved a 10-patient pilot study at 1 institution to examine the safety and efficacy of robotically assisted CABG with the Zeus Robotic Surgical System by Computer Motion (Goleta, Calif). It was stipulated that only the LITA-LAD anastomosis could be performed with the Zeus device. All other vessels were sewn by hand in the traditional fashion. Moreover, the procedure had to be performed with cardiopulmonary bypass (CPB) and cardioplegic arrest. After approval from our institutional review board, 15 patients were enrolled in the trial. Informed consent was obtained from each of the study participants. Patients were considered eligible if (1) they possessed angiographic evidence of occlusive (>50% stenosis) atherosclerotic disease of the LAD, (2) they required elective or urgent CABG surgery, and (3) they had had no previous cardiac operations. Exclusion Five enrolled patients were excluded from participation. The reasons for exclusion from the study were ejection fraction less than 40% (1 patient), the presence of a diffusely diseased or intramyocardial LAD (2 patients), myocardial infarction within 7 days of the operation (1 patient), and intraoperative hemodynamic instability before CPB (1 patient).
Operating room setup and monitoring. The patients were placed supine on the operating room table, and arterial and venous access was obtained. After induction of general anesthesia, the 3 robotic arms of the Zeus system were attached to the operating table (Fig 1, B) . The patient and the robotic arms were then prepared and draped in a sterile fashion.
LITA harvest and CPB. For the first 9 patients, a standard median sternotomy was performed and the LITA was taken down in a traditional manner. The pericardium was opened and the heart was exposed. The patient was heparinized and the activated clotting time was maintained above 450 sec- 
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onds. The ascending aorta and right atrial appendage were cannulated and CPB was established. The patient was cooled to 32°C. A cannula was placed in the aortic root for antegrade administration of cardioplegic solution and a coronary sinus catheter was placed for retrograde cardioplegia administration.
In the tenth patient, the LITA was harvested thoracoscopically through 3 endoscopic ports. The camera port was placed in the 4th intercostal space at the anterior axillary line and the 2 instrument ports were in the 2nd and 6th intercostal spaces in the mid axillary line. A small (4 cm) anterior thoracotomy was made in the 3rd intercostal space. This patient was placed on CPB with the Heartport system (Heartport, Inc, Redwood City, Calif). 12 Setup of robotic system. The Zeus Robotic Microsurgical System consisted of 2 robotic arms that were used to manipulate modified endoscopic instruments (Karl Storz, Culver City, Calif). The arms were attached to the operating table. The surgeon controlled the instruments by manipulating spe-cially designed handles at a console (Fig 2) . The handles allowed for 4 full ranges of motion (pan, roll, tilt, and in/out), as well as grasping. The surgeon's motions were directly and precisely translated from the console to the robotic arms by a computer controller. Custom-designed software allowed for tremor elimination, as well as motion scaling over a range of 2:1 to 10:1.
Three thoracoscopic ports were used to sew the anastomosis (Fig 3) . This port placement was determined from our previous animal and cadaveric experience 13 and was optimal for the LAD anastomosis in our hands. The 5-mm right instrument port (Endopath, Ethicon, Inc, Somerville, NJ) was in the midline just below the xiphoid process. The 10-mm camera port (Endopath, Ethicon) was placed approximately 7 cm lateral to the midline port in the 5th or 6th intercostal space, depending on the position of the LAD. The 5-mm left instrument port was placed 7 cm lateral to the camera port in the 6th or 7th intercostal space along the anterior axillary line. A 0°endoscope (Karl Storz) was used and attached to a 3-chip video camera (Tricam SL, Karl Storz) and light source (Zenon 300, Karl Storz). The endoscope was manipulated with the Aesop (Computer Motion) voice-controlled robotic arm. The video was monitored both at the surgeon console and on a 21-inch monitor at the head of the operating room table. The specialized instrument tips were inserted into the ports.
Administration of cardioplegic solution. In those patients who required grafts in addition to the LITA-LAD anastomosis, these grafts were performed first by means of traditional open chest methods. A crossclamp was applied to the ascending aorta, and cold blood cardioplegic solution was The positioning of the 3 ports used for the endoscopic anastomosis. A modified subxiphoid approach was used. The middle port was a 10-mm port for the camera. Two instruments were placed through lateral and medial 5-mm ports. ICS, Intercostal space. administered in an antegrade fashion to achieve arrest. Myocardial temperature was measured in the interventricular septum and maintained below 15°C. Additional cardioplegic solution was given as necessary throughout the remainder of the operation in a retrograde fashion through the coronary sinus.
In the tenth patient, the Heartport Endoclamp device was used and cardioplegic solution was administered antegradely into the aortic root. Subsequently, cardioplegic solution was administered in a retrograde fashion through a percutaneously placed coronary sinus cannula.
Robotically assisted coronary anastomosis. The heart was left in situ and was not suspended in a pericardial cradle. The chest retractor was relaxed to allow a more normal anatomic position of the chest wall. After cardioplegic arrest, an arteriotomy was made in the distal LAD. In the last 5 patients, this was done with specialized scissors and the Zeus system. A continuous end-to-side anastomosis was performed endoscopically with the robotic instruments. The heel was sewn first and parachuted down, followed by completion of the toe of the anastomosis. No manipulation of the heart was necessary to perform the anastomosis, and visualization of each stitch through the subxiphoid camera port was excellent. An assistant held the LITA pedicle through the chest incision with standard instruments. The running anastomosis was performed with a specially designed 7-cm double-armed 7-0 polytetrafluoroethylene suture. * Motion scaling (2.5:1) was used for each anastomosis. After completion of the anastomosis, the suture was tied endoscopically. No repair stitches were required. The clamp on the LITA and the aortic crossclamp were removed, and the patient was rewarmed. The patient was then weaned from CPB. Protamine sulfate was administered to reverse the heparin, and the chest was closed in a standard fashion. No patient required inotropic support.
Short-term graft flow. Blood flow through the LITA graft was measured with a 2.0-to 2.5-mm ultrasonic flow probe and flowmeter (HT311, Transonic Systems, Inc, Ithaca, NY) and was recorded with FlowTrace 32 software (Transonic Systems, Inc). If flow was not judged to be adequate, selective coronary angiography was performed in the operating suite. The LITA graft was selectively catheterized via the left radial artery. An OEC model 9600 digital imaging system was used to visualize the anastomosis (Omega Electronics Corporation, Salt Lake City, Utah).
Patient follow-up. During the postoperative period, the following data were collected: hemodynamic parameters, chest tube drainage, need for inotropic medications, length of intensive care unit stay, and length of hospital stay. Eight weeks after the operation, all patients underwent a second coronary angiogram of the LITA-LAD anastomosis to assess graft patency. Follow-up was 100%.
Results
Patient demographics. Ten (n = 10) patients took part in the study, 6 men and 4 women. The mean age was 55.8 ± 3.0 years. Ejection fraction averaged 50% ± 4%.
Intraoperative results. The robotic system was quick and easy to assemble. The average time required for setup was 14.9 ± 2.1 minutes. No intraoperative complications related to port placement were encountered, and there were no mechanical failures of the robotic system.
The total number of grafts performed was 2.3 ± 0.3 per patient with a mean crossclamp time of 51.1 ± 1.6 minutes. The time required to perform the endoscopic LITA-LAD anastomosis with the robotic system was 23.6 ± 1.4 minutes (range 18-30 minutes). All anastomoses were successfully performed and no repair stitches were required.
The patient who had a limited thoracotomy and CPB with a Heartport device had a crossclamp time of 71 minutes and an anastomosis time of 28 minutes.
All patients underwent intraoperative ultrasonic determination of flow through the LITA graft. mL/min. Two of the 10 grafts had inadequate flow and were taken down and reconstructed manually. In 1 case, the patient who had a Heartport procedure, an intraoperative coronary angiogram was performed. The graft was not visualized. However, the distal anastomosis was probe patent. A tentative diagnosis of graft spasm was made. In the second case, angiography was unavailable. Subsequent review of the videotape revealed a technical error. This case represented a failure of surgical technique, not of the robotic system. Conversion to the manual technique was easily accomplished in both patients, and all patients left the operating room with a patent LITA-LAD anastomosis. Postoperative course. There was only one postoperative complication. This patient required return to the operating room the evening of surgery for excessive mediastinal hemorrhage. The source of hemorrhage was identified as the lateral trocar insertion site. The bleeding was stopped successfully with electrocautery.
No other complications were encountered in the postoperative period. The average length of stay in the intensive care unit was 1.1 ± 1 days. The average length of stay in the hospital was 4.1 ± 0.2 days.
Late follow-up. A 100% late follow-up was achieved. The mean period of follow-up was 142.1 ± 10.7 days. No late complications occurred. All patients are presently in New York Heart Association class I.
Eight weeks after the operation, graft patency was assessed by a second coronary angiogram. These studies were all performed at our institution and revealed that 100% (8/8) of the LITA-LAD grafts were patent (Fig 4) . One graft had a 50% stenosis at its insertion site.
Discussion
Minimally invasive surgical techniques have become more prevalent in the field of cardiac surgery. The potential benefits of these approaches include decreased blood loss, lower complication rates, and shorter hospital stays. 14, 15 Early results of beating heart procedures have demonstrated acceptable graft patency and minimal morbidity in large series of patients. 2, 16 However, with conventional techniques, completely endoscopic CABG has not been possible.
Recently, robotically assisted microsurgery systems have been introduced to increase the precision of endoscopic surgery. These computer-guided systems can control both surgical instruments 8, 9 and endoscopic cameras. 17 These systems may help to overcome the obstacles to endoscopic CABG. Specifically, robotic instrumentation may provide access to multiple target vessels and offer the surgeon the ability to operate precisely in confined spaces. The most significant limitation to the use of traditional endoscopic instruments in CABG is the lack of precision that results from the additive effects of instrument length and operator tremor. Robotic microsurgical systems address this limitation by filtering high-frequency motions, thus eliminating tremor. Dexterity is further enhanced through computer motion-scaling. This allows the surgeon to make large, easy-to-perform macroscopic movements at the console and have these scaled down by the computer to microscopic movements of the instrument tip inside the patient. Endoscopic magnification of the operative site also improves the accuracy of suture placement by providing enhanced visualization. The magnification is 3 to 4 times higher than that with traditional surgical loupes.
Finally, the Zeus system incorporates a robotic voicecontrolled arm (Aesop) to control the endoscope. This eliminates the need for an assistant and has been shown to improve the stability of the image, reduce camera clearings, and decrease the operative time during surgical procedures. 17, 18 It has been our early experience that this technology greatly facilitates microsurgery. Under high magnification, a stable image is absolutely critical. Moreover, the ability to control the movement of the Aesop robotic arm by voice effectively gives the surgeon a third arm.
In previous animal studies, endoscopic CABG has been shown to be feasible with acceptable short-term and long-term graft patency. 11, 13 The present study analyzed the short-term outcome of robotically assisted endoscopic CABG in human subjects. Short-term graft patency was 80% (8/10). Conversion to manual anastomosis was easily completed in the 2 patients with inadequate flow, and all patients left the operating room with patent LITA-LAD grafts. Graft patency 2 months after the operation was 100% (8/8) as demonstrated by angiography. These results demonstrate the feasibility of endoscopic CABG. More important, no device-related complications were observed. Anastomoses can be performed with robotic assistance with acceptable short-term results. The operating room time required for equipment setup was minimal.
The principal shortcoming of this study was that it does not represent a completely endoscopic approach. Other CABGs were performed through traditional incisions. Clearly, a completely endoscopic procedure will be a greater challenge, but one that appears to be achievable.
The other parts of endoscopic CABG have been performed without a surgical incision. Heartport technology allows for CPB without the need for a thoracic incision. 19 Endoscopic LITA harvest is a widely described procedure 20, 21 and can be easily performed manually. The use of an expensive robotic system does not seem to be warranted for this part of the procedure.
